Matthew G Hanna Selected Research

Matthew G Hanna Research Topics

8	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2017
5	Neoplasms (Cancer) 01/2022 - 11/2014
2	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2014
1	Triple Negative Breast Neoplasms 01/2021
1	Margins of Excision 01/2021
1	Bites and Stings (Sting) 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Ductal Carcinoma 01/2021
1	Dysplastic Nevus Syndrome (Dysplastic Nevus) 01/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Eosinophilic Esophagitis 01/2016
1	Candidiasis (Moniliasis) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2015

3	Hematoxylin (Haematoxylon)IBA 05/2022 - 11/2014
3	Eosine Yellowish-(YS) (Eosin)IBA 05/2022 - 11/2014
2	SolutionsIBA 01/2021 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2019
2	Estrogen ReceptorsIBA 01/2017 - 11/2014
1	ParaffinIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Formaldehyde (Formol)FDA Link 01/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	atezolizumabIBA 01/2021
1	Everolimus FDA Link 01/2020
1	Hormones (Hormone)IBA 01/2020
1	palbociclibIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2019
1	human ERBB2 proteinIBA 10/2019
1	ChromatinIBA 01/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016
1	Fluticasone (Cutivate)FDA LinkGeneric 01/2016
1	CrizotinibIBA 01/2015
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	Keratins (Keratin)IBA 11/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 11/2014

2	Immunotherapy 01/2021 - 01/2021
2	Therapeutics 01/2020 - 01/2016
1	Segmental Mastectomy (Lumpectomy) 01/2021